Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Jens Plaschke - , Abteilung Chirurgische Forschung (Autor:in)
  • Stefan Krüger - , Abteilung Chirurgische Forschung (Autor:in)
  • Wolfgang Dietmaier - , Universität Regensburg (Autor:in)
  • Johannes Gebert - , Universität Regensburg (Autor:in)
  • Christian Sutter - , Universität Regensburg (Autor:in)
  • Elisabeth Mangold - , Universitätsklinikum Bonn (Autor:in)
  • Constanze Pagenstecher - , Universitätsklinikum Bonn (Autor:in)
  • Elke Holinski-Feder - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Karsten Schulmann - , Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH (Autor:in)
  • Gabriela Möslein - , Heinrich Heine Universität Düsseldorf (Autor:in)
  • Josef Rüschoff - , Klinikum Kassel GmbH (Autor:in)
  • Christoph Engel - , Universität Leipzig (Autor:in)
  • Gareth Evans - , St. Mary's Hospital (Autor:in)
  • Hans K. Schackert - , Abteilung Chirurgische Forschung (Autor:in)

Abstract

Germline mutations in mismatch repair (MMR) genes, predominantly in MLH1 and MSH2, are responsible for hereditary nonpolyposis colorectal cancer (HNPCC), a cancer-susceptibility syndrome with high penetrance. In addition, MSH6 mutations have been reported to account for about 10% of all germline mismatch repair (MMR) gene mutations in HNPCC patients, and have been associated with a later age of onset of the disease compared to MLH1 and MSH2 mutations. Here, we report eight novel germline mutations in MSH6. The patients were selected by having developed tumors with loss of MSH6 protein expression. All tumors showed high-level microsatellite instability (MSI-H). Seven mutations resulted in premature stop codons, comprised of two nonsense mutations (c.426G>A [p.W142X], c.2105C>A [p.S702X]), two insertions (c.2611_2614dupATTA [p.I872fsX10], c.3324dupT [p.I1109fsX3]) and three deletions (c.1190_1191delAT [p.Y397fsX3], c.1632_1635delAAAA [p.E544fsX26], c.3513_3514delTA [p.1171fsX5]). In addition, an amino acid substitution of an arginine residue (c.2314C>T [p.R772W]) conserved throughout a wide variety of mutS homologs has been found in a patient not fulfilling the Bethesda criteria for HNPCC. Our results emphasize the suitability of IHC as a pre-selection tool for MSH6 mutation analysis and the high frequency of germline mutation detection in patients with MSH6-deficient tumors. In addition, our findings point towards a broad variability regarding penetrance associated with MSH6 germline mutations.

Details

OriginalspracheEnglisch
Seiten (von - bis)285
Seitenumfang1
FachzeitschriftHuman mutation
Jahrgang23
Ausgabenummer3
PublikationsstatusVeröffentlicht - März 2004
Peer-Review-StatusJa

Externe IDs

PubMed 14974087

Schlagworte

Ziele für nachhaltige Entwicklung

ASJC Scopus Sachgebiete